secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nano Dimension Ltd. (NNDM)
CIK:        0001643303
Form:       8-K
Filed at:   2026-06-15T11:48:12+00:00
Accession:  0001104659-26-073776
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nano Dimension signs non-binding term sheet to acquire Infinite Epigenetics for $890M stock consideration
--------------------------------------------------------------------------------

- Infinite valued at $890M; Nano valuation based on net cash plus 20% premium plus ~$20M for Essemtec.
- Post-closing, Infinite shareholders to own majority; if >55%, they designate 5 of 7 board seats.
- Nano will spin off legacy assets via CVR to pre-closing Nano shareholders.
- Term sheet includes 30-day exclusivity; no definitive agreement yet.
- Nano to reimburse Infinite up to $3M expenses if definitive deal not signed by EGM date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1643303/000110465926073776/0001104659-26-073776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1643303/000110465926073776/tm2617934d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-073776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer